In this issue:
- Real-world evidence of the effectiveness and safety of cladribine in MS
- Benefits of supervised Pilates-based core stability training in pwMS
- Body mass index as a predictor of MS activity and progression
- Pelvic floor muscle training for urinary incontinence in pwMS
- Prodromal emesis in patients with MOGAD
- Menopause and MS
- SARS-CoV-2 antibody responses after 2 doses of mRNA vaccine in pwMS taking DMTs
- A third SARS-CoV-2 vaccine dose in pwMS with a weak response to 2 doses
- Risk of severe COVID-19 infection in Swedish patients taking rituximab
- MS disease activity and disability after discontinuation of natalizumab for pregnancy
Please login below to download this issue (PDF)